======= RANBP9 ======= == Gene Information == * **Official Symbol**: RANBP9 * **Official Name**: RAN binding protein 9 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10048|10048]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q96S59|Q96S59]] * **Interactions**: [[https://thebiogrid.org/search.php?search=RANBP9&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20RANBP9|Open PubMed]] * **OMIM**: [[https://omim.org/entry/603854|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: May act as an adapter protein to couple membrane receptors to intracellular signaling pathways. May be involved in signaling of ITGB2/LFA-1 and other integrins. Enhances HGF-MET signaling by recruiting Sos and activating the Ras pathway. Enhances dihydrotestosterone-induced transactivation activity of AR, as well as dexamethasone-induced transactivation activity of NR3C1, but not affect estrogen-induced transactivation. Stabilizes TP73 isoform Alpha, probably by inhibiting its ubiquitination, and increases its proapoptotic activity. Inhibits the kinase activity of DYRK1A and DYRK1B. Inhibits FMR1 binding to RNA. {ECO:0000269|PubMed:12147692, ECO:0000269|PubMed:12361945, ECO:0000269|PubMed:14500717, ECO:0000269|PubMed:14722085, ECO:0000269|PubMed:15381419, ECO:0000269|PubMed:15558019, ECO:0000269|PubMed:18222118}. |RanBPM CRA| |LisH| |SPRY| |microtubule nucleation| |microtubule associated complex| |microtubule polymerization| |Ran GTPase binding| |microtubule polymerization or depolymerization| |negative regulation of ERK1 and ERK2 cascade| |protein polymerization| |ubiquitin ligase complex| |negative regulation of MAPK cascade| |axon guidance| |neuron projection guidance| |regulation of ERK1 and ERK2 cascade| |enzyme binding| |axonogenesis| |MAPK cascade| |signal transduction by protein phosphorylation| |negative regulation of protein phosphorylation| |axon development| |cell morphogenesis involved in neuron differentiation| |negative regulation of phosphorylation| |supramolecular fiber organization| |microtubule cytoskeleton organization| |neuron projection morphogenesis| |plasma membrane bounded cell projection morphogenesis| |cell projection morphogenesis| |negative regulation of intracellular signal transduction| |cell part morphogenesis| |chemotaxis| |taxis| |cell morphogenesis involved in differentiation| |negative regulation of phosphate metabolic process| |negative regulation of phosphorus metabolic process| |negative regulation of protein modification process| |neuron projection development| |microtubule-based process| |cell morphogenesis| |regulation of MAPK cascade| |neuron development| |cellular component morphogenesis| |cellular protein-containing complex assembly| |protein phosphorylation| |neuron differentiation| |negative regulation of cellular protein metabolic process| |negative regulation of protein metabolic process| |cytoskeleton organization| |plasma membrane bounded cell projection organization| |cell projection organization| |negative regulation of signal transduction| |phosphorylation| |locomotion| |negative regulation of cell communication| |negative regulation of signaling| |regulation of protein phosphorylation| |generation of neurons| |movement of cell or subcellular component| |protein-containing complex assembly| |regulation of phosphorylation| |negative regulation of response to stimulus| |neurogenesis| |cell development| |intracellular signal transduction| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of intracellular signal transduction| |regulation of protein modification process| |protein-containing complex subunit organization| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp502|Milciclib 2μM R08 exp502]]|-1.85| |[[:results:exp152|SGC2043 10μM R03 exp152]]|-1.79| |[[:results:exp75|MK-1775 0.32μM R02 exp75]]|-1.7| |[[:results:exp19|Etoposide 1μM R00 exp19]]|1.8| |[[:results:exp233|EPZ-5676 30μM R05 exp233]]|1.92| |[[:results:exp21|MLN-4924 0.2μM R00 exp21]]|2.34| |[[:results:exp25|Oligomycin-A 2μM R00 exp25]]|2.72| |[[:results:exp3|Actinomycin-D 0.001μM R00 exp3]]|2.81| |[[:results:exp485|GSK626616 14μM R08 exp485]]|3.25| ^Gene^Correlation^ |[[:human genes:m:maea|MAEA]]|0.468| |[[:human genes:u:ube2h|UBE2H]]|0.444| |[[:human genes:g:gid8|GID8]]|0.42| |[[:human genes:h:hars|HARS]]|0.4| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 11743 * **Expression level (log2 read counts)**: 6.23 {{:chemogenomics:nalm6 dist.png?nolink |}}